These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 5067045)
1. [Drug therapy of cerebrovascular occlusive disease--special reference to administration of dextran sulfate as a fibrinolytic agent]. Sato I; Nagai M; Sano K; Tsuchida M; Ishijima B No To Shinkei; 1972 Mar; 14(3):295-9. PubMed ID: 5067045 [No Abstract] [Full Text] [Related]
2. [Application of fibrinolytic therapy to cerebrovascular obstruction, with special reference to regional perfusion with urokinase]. Handa H; Yoshida K; Takase T; Aoyagi M; Ebina K Nihon Rinsho; 1968 Jul; 26(7):1657-75. PubMed ID: 5751018 [No Abstract] [Full Text] [Related]
3. [On some unusual aspects of fibrinolytic therapy in patients with carotid obstruction complicated by a stroke]. Ambrosio A; Palmieri A; Profeta G; Maggi G Rass Int Clin Ter; 1970 Apr; 50(8):498-508. PubMed ID: 5476587 [No Abstract] [Full Text] [Related]
10. [Anticoagulation and antiplatelet therapy in cerebrovascular diseases]. Shio H Nihon Ronen Igakkai Zasshi; 1986 Jul; 23(4):358-61. PubMed ID: 3784090 [No Abstract] [Full Text] [Related]
11. Advances in stroke therapy: introduction to cerebral angioplasty and cerebral thrombolysis. Evans AJ; Evans JA J Fla Med Assoc; 1997; 84(4):235-8. PubMed ID: 9342910 [No Abstract] [Full Text] [Related]
12. [Internal medicine and neurosurgery, with special reference to cerebral angiography in cerebrovascular disorders]. Goto Y; Murakami K; Sawata T; Tatsuzawa Y; Mihara H Saishin Igaku; 1966 Jul; 21(7):1432-8. PubMed ID: 5967535 [No Abstract] [Full Text] [Related]
13. Small but severe residual hypoperfusion relates to symptomatic hemorrhage even after early perfusion improvement in tissue plasminogen activator therapy. Abumiya T; Katoh M; Moriwaki T; Yoshino M; Aoki T; Imamura H; Aida T; Nakayama N; Houkin K Cerebrovasc Dis; 2012; 34(5-6):446-7. PubMed ID: 23207677 [No Abstract] [Full Text] [Related]
14. [Randiomized trial of a new platelet anti-aggregant agent: ticlopidine]. Lecrubier C; Conard J; Samama M; Bousser MG Therapie; 1977; 32(2):189-94. PubMed ID: 331552 [No Abstract] [Full Text] [Related]
15. [Thrombolytic preparations and anticoagulants in the treatment of patients with thrombotic stroke]. Koniukhov SG; Liberzon SP Vrach Delo; 1974 Aug; 0(8):21-3. PubMed ID: 4411277 [No Abstract] [Full Text] [Related]
16. Treatment of strokes. I. Browne TR; Poskanzer DC N Engl J Med; 1969 Sep; 281(11):594-602. PubMed ID: 4897138 [No Abstract] [Full Text] [Related]
17. [Angiocyclan in the treatment of vascular diseases. Controlled clinical results]. Bracale GC; Renda A Minerva Cardioangiol; 1975 Mar; 23(3):170-6. PubMed ID: 1128768 [No Abstract] [Full Text] [Related]
18. Using antithrombotic therapy in ischemic cerebrovascular disease. Gotshall RA; Harker LA Geriatrics; 1977 Nov; 32(11):101-4. PubMed ID: 924145 [No Abstract] [Full Text] [Related]
19. Thrombolysis after stroke. Fieschi C; Toni D Lancet; 1996 Oct; 348(9033):1035. PubMed ID: 8855886 [No Abstract] [Full Text] [Related]
20. [Combined therapy with vasodilator and lipid-clearing drugs in cerebrovascular insufficiency in advanced old age]. Giovanardi F; Bisceglia G Clin Ter; 1971 Aug; 58(3):243-53. PubMed ID: 5135003 [No Abstract] [Full Text] [Related] [Next] [New Search]